Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study

Open Access

Peer-reviewed

Research Article

Yong Kyu Lee,

Affiliation Nephrology Division, Internal Medicine Department, National Health Institute Corporation, Ilsan Hospital, Goyang, Republic of Korea
⨯
Hae Won Lee,

Affiliation Nephrology Division, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
⨯
Kyu Hun Choi,

Affiliation Nephrology Division, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
⨯
Beom Seok Kim

* E-mail: docbsk@yuhs.ac

Affiliation Nephrology Division, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
⨯

Reader Comments (0)

Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Blood transfusion
Is the Subject Area "Blood transfusion" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Gastrointestinal infections
Is the Subject Area "Gastrointestinal infections" applicable to this article?

Thanks for your feedback.
Heparin
Is the Subject Area "Heparin" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Gynecologic infections
Is the Subject Area "Gynecologic infections" applicable to this article?

Thanks for your feedback.